Joint statement appeals to maintain paper medicine package leaflets, and use electronic leaflets as a complementary tool
Ahead of the future co-legislators’ interinstitutional negotiations on the European Commission’s Proposal for a revised pharmaceutical legislation in the European Union, the signatory organisations appeal for inclusive provisions that leave no one behind and are respectful of privacy and personal data protection.
Jointly, the organisations call upon the co-legislators to:
Contribute to an inclusive society, without enacting discriminatory rules that increase the digital divide and limit individuals’ choice
Recognise the importance of the package leaflet as a key tool for information accessibility
Balance the advantages and disadvantages of ePI
Protect patients’ privacy and guarantee that the information is not used for commercial purposes
Listen to patients and other end users as an evidence-base for action
Read the full joint statement here.
Image: iStock / Cunaplus_M.Faba